Australia Veterinary Clinical Trials Market Size & Outlook
Related Markets
Australia veterinary clinical trials market highlights
- The Australia veterinary clinical trials market generated a revenue of USD 84.0 millions in 2023 and is expected to reach USD 165.2 millions by 2030.
- The Australia market is expected to grow at a CAGR of 10.1% from 2024 to 2030.
- In terms of segment, companion animal was the largest revenue generating animal type in 2023.
- Companion Animal is the most lucrative animal type segment registering the fastest growth during the forecast period.
Veterinary clinical trials market data book summary
| Market revenue in 2023 | USD 84.0 millions |
| Market revenue in 2030 | USD 165.2 millions |
| Growth rate | 10.1% (CAGR from 2023 to 2030) |
| Largest segment | Companion animal |
| Fastest growing segment | Companion Animal |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD millions |
| Market segmentation | Companion Animal, Livestock Animal, Other Animals |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global veterinary clinical trials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China veterinary clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 791.8 millions by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Clinical Trials Market Scope
Veterinary Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Banco Bilbao Vizcaya Argentaria SA ADR | View profile | 121563 | Calle Azul, 4, Madrid, Spain, 28050 | https://www.bbva.com |
| Vivesto AB ADR | View profile | 6 | Gustav III:s Boulevard 46, 5th Floor, Solna, Sweden, SE-169 73 | https://www.vivesto.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| IDEXX Laboratories Inc | View profile | 11000 | One IDEXX Drive, Westbrook, ME, United States, 04092 | https://www.idexx.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Australia veterinary clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary clinical trials market will help companies and investors design strategic landscapes.
Companion animal was the largest segment with a revenue share of 61.67% in 2023. Horizon Databook has segmented the Australia veterinary clinical trials market based on companion animal, livestock animal, other animals covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia veterinary clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia veterinary clinical trials market databook
-
Our clientele includes a mix of veterinary clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia veterinary clinical trials market, including forecasts for subscribers. This country databook contains high-level insights into Australia veterinary clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia veterinary clinical trials market size, by animal type, 2018-2030 (US$Ms)
Australia Veterinary Clinical Trials Market Share, 2023 & 2030 (US$Ms)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
